Moolec Science SA (NASDAQ:MLEC) Short Interest Up 463.9% in December

Moolec Science SA (NASDAQ:MLECGet Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totaling 203,239 shares, a growth of 463.9% from the December 15th total of 36,041 shares. Based on an average daily trading volume, of 854,033 shares, the days-to-cover ratio is currently 0.2 days. Currently, 34.9% of the company’s shares are sold short. Currently, 34.9% of the company’s shares are sold short. Based on an average daily trading volume, of 854,033 shares, the days-to-cover ratio is currently 0.2 days.

Moolec Science Stock Down 21.5%

Shares of Moolec Science stock traded down $1.06 during trading on Wednesday, hitting $3.86. The stock had a trading volume of 85,159 shares, compared to its average volume of 145,263. Moolec Science has a 1 year low of $3.08 and a 1 year high of $157.05. The stock has a 50 day simple moving average of $6.09 and a 200 day simple moving average of $23.69. The company has a market capitalization of $2.80 million, a PE ratio of -0.12 and a beta of -0.48.

Institutional Trading of Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new position in Moolec Science SA (NASDAQ:MLECFree Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science as of its most recent SEC filing. 0.07% of the stock is currently owned by institutional investors and hedge funds.

About Moolec Science

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

See Also

Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.